RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Seattle, WA · +17 more sites
6 recruiting lupus studies with a site in Seattle, WA.
Sponsor: Amgen
Seattle, WA · +17 more sites
Sponsor: Children's Hospital Medical Center, Cincinnati
Seattle, WA · +18 more sites
Sponsor: AstraZeneca
Seattle, WA · +14 more sites
Sponsor: Seattle Children's Hospital
Seattle, WA
Sponsor: Michigan State University
Seattle, WA · +5 more sites
Sponsor: Bristol-Myers Squibb
Seattle, WA · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.